Form D · Other
Unvaas Lifesci I LP
New York, NY · CIK 0001830309
Offering snapshot reported Oct 28, 2020 · SEC filing
- Reported sold
- $517K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $150K Reported outside-investor minimum
- First sale
- Sep 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2020 | Initial | $516,667 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-379104
Source: Form D, filed Oct 28, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jun Chul Whang | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1280 Fifth Avenue 19 G
New York, NY, 10029
New York, NY, 10029